Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 887.7 Thousand USD | 338.11% |
| 2019 | 202.62 Thousand USD | -71.65% |
| 2018 | 714.76 Thousand USD | 48.23% |
| 2017 | 482.2 Thousand USD | -19.07% |
| 2016 | 595.8 Thousand USD | -73.81% |
| 2015 | 2.27 Million USD | 232178.97% |
| 2014 | 979.45 USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 5.2 Million USD | -31.2% |
| 2008 | 7.56 Million USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2021 Q1 | 845.86 Thousand USD | -4.71% |
| 2021 FY | - USD | -100.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2020 Q2 | 299.37 Thousand USD | -6.81% |
| 2020 Q1 | 321.24 Thousand USD | 58.54% |
| 2020 Q4 | 887.7 Thousand USD | 59.73% |
| 2020 Q3 | 555.74 Thousand USD | 85.63% |
| 2020 FY | 887.7 Thousand USD | 338.11% |
| 2019 Q3 | 742.86 Thousand USD | 2.36% |
| 2019 FY | 202.62 Thousand USD | -71.65% |
| 2019 Q4 | 202.62 Thousand USD | -72.72% |
| 2019 Q2 | 725.73 Thousand USD | -48.65% |
| 2019 Q1 | 1.41 Million USD | 97.74% |
| 2018 Q4 | 714.76 Thousand USD | -42.31% |
| 2018 FY | 714.76 Thousand USD | 48.23% |
| 2018 Q3 | 1.23 Million USD | 132.08% |
| 2018 Q2 | 533.8 Thousand USD | 7.06% |
| 2018 Q1 | 498.59 Thousand USD | 3.4% |
| 2017 Q2 | 49.53 Thousand USD | -91.81% |
| 2017 Q1 | 604.51 Thousand USD | 1.46% |
| 2017 FY | 482.2 Thousand USD | -19.07% |
| 2017 Q4 | 482.2 Thousand USD | 0.99% |
| 2017 Q3 | 477.48 Thousand USD | 863.94% |
| 2016 Q1 | 1.8 Million USD | 79106.42% |
| 2016 Q4 | 595.8 Thousand USD | -68.69% |
| 2016 FY | 595.8 Thousand USD | -73.81% |
| 2016 Q3 | 1.9 Million USD | 2.71% |
| 2016 Q2 | 1.85 Million USD | 2.83% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | 2275.07 USD | 0.0% |
| 2015 FY | 2.27 Million USD | 232178.97% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | 979.45 USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | 5.2 Million USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 FY | 5.2 Million USD | -31.2% |
| 2009 Q1 | 7.56 Million USD | 0.0% |
| 2009 Q2 | - USD | -100.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | 7.56 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BioElectronics Corporation | 12.52 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | 100.0% |
| Polarean Imaging plc | 74.84 Thousand USD | 100.0% |
| Avitar, Inc. | 3.89 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| IR-Med Inc. | 161 Thousand USD | 100.0% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 100.0% |
| Manhattan Scientifics, Inc. | - USD | NaN% |
| Össur hf. | 311.8 Million USD | 100.0% |
| Zecotek Photonics Inc. | - USD | NaN% |
| QHSLab, Inc. | - USD | NaN% |
| Wellstar International, Inc. | 18.86 Million USD | 100.0% |
| Össur hf. | 311.8 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 100.0% |
| Escalon Medical Corp. | 279.4 Thousand USD | 100.0% |
| Aurora Spine Corporation | 1.59 Million USD | 100.0% |
| BrainsWay Ltd. | 239 Thousand USD | 100.0% |
| NewCardio, Inc. | - USD | NaN% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 100.0% |
| Vivos Inc. | - USD | NaN% |
| MicroPort Scientific Corporation | 814.21 Million USD | 100.0% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 100.0% |
| Nanomix Corporation | 10.11 Million USD | 100.0% |
| Theraclion SA | 1.95 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 100.0% |
| Positron Corporation | - USD | NaN% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 150 Thousand USD | 100.0% |
| Lombard Medical, Inc. | 28.02 Million USD | 100.0% |
| ALR Technologies Inc. | - USD | NaN% |
| Stratec SE | 89.25 Million USD | 100.0% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 100.0% |
| Heart Tronics, Inc. | - USD | NaN% |
| Nu-Med Plus, Inc. | - USD | NaN% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 100.0% |
| VMS Rehab Systems, Inc. | 106.45 USD | 100.0% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 100.0% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | - USD | NaN% |
| United American Healthcare Corporation | - USD | NaN% |
| ECGI Holdings, Inc. | 804 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | - USD | NaN% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 100.0% |
| Urologix, Inc. | 4.58 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 100.0% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 100.0% |
| SS Innovations International, Inc. | 1.91 Million USD | 100.0% |
| Qualis Innovations, Inc. | - USD | NaN% |
| Smith & Nephew plc | 2.17 Billion USD | 100.0% |
| NIOX Group Plc | 500 Thousand USD | 100.0% |
| Fuse Medical, Inc. | 200 Thousand USD | 100.0% |
| Broncus Holding Corporation | 1.22 Million USD | 100.0% |
| Brain Scientific Inc. | 7378.00 USD | 100.0% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | 100.0% |
| Health Logic Interactive Inc. | - USD | NaN% |